NCT06266091 2025-07-20Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific AntibodyWuhan YZY Biopharma Co., Ltd.Phase 2 Completed115 enrolled
NCT06432296 2025-07-20Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific AntibodyWuhan YZY Biopharma Co., Ltd.Phase 3 Active not recruiting312 enrolled